However, Shimada et al.[4] and Manara et al.[31] (excluded from the systematic review because they were letters to the editor) both found that KIT mutations adversely affected the OS, DFS, or relapse rate of pediatric patients with t(8,21) AML. Here, KIT is linked to acute myeloid leukemia.